Michael Esquerré is currently the Vice-President of Immuno-Oncology at Evotec, leading projects in Immuno-Oncology therapeutics. They hold a PhD in Immunology and have over 17 years of experience in the discovery of immunotherapies, progressing from target identification to Phase II clinical trials in both the US and EU. Their expertise encompasses T cell immunology, vaccine development, and preclinical to clinical development processes. Previously, they served in various scientific and leadership roles, supporting R&D teams and managing collaborations in both academic and pharmaceutical settings. Michael has contributed to a significant number of publications and patents in the field.
This person is not in any teams
This person is not in any offices